FIELD: medicine, pharmaceutics.
SUBSTANCE: invention concerns new polymorphic modifications of semicalcium of atorvastatin salt by which names Form VI are appropriated, Form VIII, Form IX, Form X, Form XI and Form XII, and to ways of their obtaining, and also ways of obtaining of semicalcium atorvastatin salt polymorphic modifications Form I, Form II, Form IV and Form V, and also amorphous semicalcium atorvastatin salt. Use of new forms in pharmaceutical compositions raises their quality and, thereby, the control over low density lipoproteins level.
EFFECT: provision of the best control over low density lipoproteins level.
61 cl, 26 dwg, 42 ex; 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL POLYMORPHOUS FORM OF CRYSTALLINE HEMICALCIUM SALT OF ATORVASTATIN | 2006 |
|
RU2409563C2 |
| FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES | 2002 |
|
RU2294924C2 |
| CRYSTALLINE FORMS VI AND VII OF ATORVASTATIN CALCIUM SALT | 2002 |
|
RU2304139C2 |
| SALTS AND POLYMORPHIC MODIFICATIONS OF THE INHIBITOR VEGF-R | 2006 |
|
RU2369607C1 |
| POLYMORPHIC MODIFICATION OF A IBANDRONATE | 2006 |
|
RU2368617C2 |
| CRYSTALLINE MODIFICATIONS | 2005 |
|
RU2400479C2 |
| NOVEL POLYMORPHS AND SALTS | 2011 |
|
RU2573384C2 |
| IBANDRONATE POLYMORPH B | 2006 |
|
RU2387661C2 |
| POLYMORPHIC FORMS OF ICOTINIB AND USES THEREOF | 2014 |
|
RU2710013C2 |
| RIFAXIMINE POLYMORPHOUS FORMS, METHODS FOR THEIR PREPARING AND THEIR USING IN MEDICINAL PREPARATIONS | 2004 |
|
RU2270200C2 |
